Table 2 Multivariate Cox regression analysis of BCL11A and survival in patients with early stage cancer (IA–IIB)
Variable | Hazards ratio (95% CI) | Unfavorable / favorable | P value |
|---|---|---|---|
OS | Â | Â | Â |
Age | 1.07 (1.03– 1.12) | ≥ 60/< 60 | 0.002 |
Tumor size | 1.29 (1.08– 1.57) | ≥ 3 cm/< 3 cm | 0.007 |
Lymph node status | 9.09 (3.58– 23.8) | Positive/negative | 0.000 |
Performance status | 2.46 (1.06– 5.68) | 1-2/0 | 0.036 |
BCL11A protein | 0.27 (0.11– 0.69) | Higher/lower | 0.006 |
Histological type | Â | Â | 0.003 |
SCC# | 0.16 (0.05– 0.54) | SCC/AC | 0.003 |
LCC※ | 0.10 (0.03– 0.38) | LCC/AC | 0.001 |
DFS | Â | Â | Â |
Tumor size | 1.32 (1.11– 1.56) | ≥ 3 cm/< 3 cm | 0.002 |
Lymph node status | 2.56 (1.32– 5.00) | Positive/negative | 0.006 |
BCL11A protein | 0.25 (0.12– 0.51) | Higher/lower | 0.001 |